Tocilizumab for COVID-19: a real 'miracle drug'?

Infect Dis (Lond). 2020 Sep;52(9):681-682. doi: 10.1080/23744235.2020.1780307. Epub 2020 Jun 17.

Authors

Sundus Nasim¹, Shariq Haider Hashmi², Dua Azim¹, Sohail Kumar¹, Jasia Nasim¹

Affiliations

¹ Dow Medical College, Dow University of Health Sciences, Karachi, Pakistan.
² NYU Grossman School of Medicine, New York City, NY, USA.

PMID: 32644027
DOI: 10.1080/23744235.2020.1780307

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Betacoronavirus
COVID-19
Coronavirus Infections*
Disease Progression
Humans
Pandemics*
Pneumonia, Viral*
Retrospective Studies
Risk Factors
SARS-CoV-2

Substances

Antibodies, Monoclonal, Humanized
tocilizumab